Healthcare Realty Trust Inc. - Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. Healthcare Realty Trust Inc. (HR) is a real estate investment trust (REIT) focused on outpatient healthcare properties. As of the reporting date, the Company owned or had an interest in approximately 502 consolidated properties totaling roughly 29.0 million square feet across 27 states, with a gross investment of approximately $10.3 billion. The Company operates as a single reportable segment.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenues | $279.0 million | $299.0 million |
| Net Income (Loss) | $21,000 | $(45.4 million) |
| Net Loss Attributable to Common Stockholders | $(56,000) | $(44.9 million) |
| Funds From Operations (FFO) | $123.7 million | $123.8 million |
| Normalized FFO | $144.4 million | $137.7 million |
| Funds Available for Distribution (FAD) | $112.9 million | $102.2 million |
| Cash Flow from Operating Activities | $52.9 million | $47.8 million |
| Total Debt (Notes and Bonds Payable) | $4.10 billion | $3.91 billion |
| Cash and Cash Equivalents | $26.2 million | $25.7 million |
| Dividends Declared (per share) | $0.24 | $0.31 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 6.7% year-over-year, driven primarily by a $21.3 million decrease in rental income due to property dispositions ($32.8 million impact) partially offset by leasing activity ($10.9 million increase).
- Profitability Improvement: The Company reported a net income of $21,000 compared to a net loss of $45.4 million in Q1 2025. This turnaround was significantly aided by a $10.8 million gain on sales of real estate (vs. $2.9 million in 2025) and a $1.0 million credit loss recovery, contrasting with $12.1 million in impairment charges in the prior year.
- Expense Management: Property operating expenses decreased 9.0% to $100.1 million, largely due to dispositions. However, General and Administrative (G&A) expenses increased 28.2% to $17.3 million, primarily due to $7.1 million in restructuring and severance charges.
- Interest Expense: Interest expense decreased 19.9% to $43.9 million, driven by lower contractual interest on term loans and the repayment of Senior Notes due 2025.
- Capital Deployment: The Company disposed of three properties for net proceeds of $30.0 million. It also repurchased 5.7 million shares of common stock for approximately $100 million.
Outlook, Risks, and Management Commentary
- Liquidity: The Company maintains $1.2 billion in availability on its $1.5 billion Revolving Credit Facility and established a new $600 million Commercial Paper Program in February 2026, with $251 million outstanding as of quarter-end. Management believes liquidity is adequate for short and long-term needs.
- Dividends: A quarterly dividend of $0.24 per share was declared for Q1 2026, a reduction from the $0.31 per share paid in Q1 2025. Dividends were funded by operating cash flows and the Revolving Facility.
- Lease Expirations: Approximately 10-15% of leases are expected to expire annually. For the remainder of 2026, 768 leases totaling 2.2 million square feet will expire. Management expects a retention ratio of 75% to 90%.
- Risks: Key risks include tenant financial viability (specifically referencing the ongoing impact of the Prospect Medical bankruptcy), interest rate volatility, property tax increases, and the inability to re-let properties at favorable rates. The filing also notes risks associated with the "One Big Beautiful Bill Act" passed in 2025, which is subject to ongoing analysis regarding its impact on healthcare demand.
- Unusual Items: The quarter included significant non-recurring items such as restructuring charges ($7.6 million included in Normalized FFO adjustments) and gains on property sales.
Investor Verification Checklist
- Dividend Sustainability: Verify the rationale for the dividend reduction from $0.31 to $0.24 per share and the Company's ability to maintain the new rate given the reliance on the Revolving Facility to fund distributions in Q1.
- Restructuring Costs: Confirm the nature and duration of the $7.1 million in restructuring and severance charges included in G&A expenses to assess future run-rate profitability.
- Tenant Concentration: Review the specific exposure to the Prospect Medical bankruptcy and other major health systems to evaluate credit risk in the portfolio.
- Debt Maturity Profile: Analyze the maturity schedule of the $4.1 billion debt portfolio, particularly the $597 million Senior Notes due in August 2026, to assess refinancing risks.
- Same-Store Performance: Validate the 7.1% increase in Same Store Cash NOI ($153.6 million vs. $143.5 million) to ensure organic growth is offsetting the impact of dispositions.